Gelteq Limited (GELS)
Nasdaq: GELS · Pharmaceutical Preparations · filing with the SEC since 2022
Who runs Gelteq Limited
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Givoni Nathan J
Chief Executive Officer. First filing Mar 2026, latest Mar 18, 2026, 0 filings in all.
Officers reporting now
3
of 4 people with a filing in the last fifteen months
Directors reporting now
1
4 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Givoni Nathan J | Chief Executive Officer | Mar 2026 | Mar 18, 2026 | none |
| Wynne Paul Michael | Chief Scientific Officer | Mar 2026 | Mar 18, 2026 | none |
| Karp Bradley Glenn | Head of Sales and Marketing | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Szewach Simon H | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.